UNRESECTABLE SALIVARY GLAND CARCINOMA
Clinical trials for UNRESECTABLE SALIVARY GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE SALIVARY GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE SALIVARY GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on Hard-to-Treat cancers shows early promise
Disease control OngoingThis early-phase trial tests a combination of two drugs—trastuzumab deruxtecan (a targeted chemotherapy) and ceralasertib (which blocks a DNA repair enzyme)—in people with advanced solid tumors that have a HER2 mutation. The goal is to find the safest dose and see if the combo wo…
Matched conditions: UNRESECTABLE SALIVARY GLAND CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
Hormone therapy duo takes on rare salivary cancer
Disease control OngoingThis study tests two drugs that block male hormones to slow or shrink a rare type of salivary gland cancer that has spread or come back. About 21 people whose cancer has not been treated with hormone therapy before will take darolutamide (a pill) and leuprolide (an injection). Th…
Matched conditions: UNRESECTABLE SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:27 UTC